New York Health Care, Inc. (BBAL)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 19, 2025, 4:00 PM EDT
New York Health Care Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | 2001 - 2002 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '08 Sep 30, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 | 2001 - 2002 |
| Revenue | 45.78 | 44.4 | 45.3 | 44.46 | 42.2 | 38.52 | Upgrade
|
| Revenue Growth (YoY) | 4.08% | -2.00% | 1.91% | 5.36% | 9.54% | - | Upgrade
|
| Cost of Revenue | 38.43 | 36.63 | 36.75 | 37.08 | 34.78 | 31.86 | Upgrade
|
| Gross Profit | 7.35 | 7.77 | 8.56 | 7.38 | 7.42 | 6.66 | Upgrade
|
| Selling, General & Admin | 6.02 | 7.15 | 9.1 | 13.01 | 10.03 | 9.14 | Upgrade
|
| Research & Development | 0.28 | 0.65 | 1.64 | 2.8 | 1.06 | 1.24 | Upgrade
|
| Operating Expenses | 6.55 | 8.2 | 11.42 | 16.47 | 11.9 | 10.93 | Upgrade
|
| Operating Income | 0.8 | -0.43 | -2.86 | -9.09 | -4.49 | -4.27 | Upgrade
|
| Interest Expense | -0.06 | -0.03 | -0.06 | -0.02 | -0.03 | -0 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.08 | 0.16 | 0.09 | 0.07 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.19 | 0.19 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 1.03 | -0.19 | -2.75 | -9.03 | -4.45 | -4.22 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -17.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.06 | -0.06 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.73 | -0.73 | -0.93 | - | -1.74 | - | Upgrade
|
| Pretax Income | 0.24 | -0.98 | -3.68 | -9.03 | -6.19 | -22.09 | Upgrade
|
| Income Tax Expense | 0.05 | 0.07 | 0.08 | 0.08 | -0.07 | 0.03 | Upgrade
|
| Earnings From Continuing Operations | 0.19 | -1.05 | -3.76 | -9.1 | -6.12 | -22.12 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 2.78 | 0.05 | 0.07 | Upgrade
|
| Net Income | 0.22 | -1.05 | -3.76 | -6.32 | -6.07 | -22.05 | Upgrade
|
| Net Income to Common | 0.22 | -1.05 | -3.76 | -6.32 | -6.07 | -22.05 | Upgrade
|
| Shares Outstanding (Basic) | 34 | 34 | 33 | 32 | 25 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 34 | 33 | 32 | 25 | 24 | Upgrade
|
| Shares Change (YoY) | 0.30% | 0.86% | 4.25% | 27.89% | 2.70% | 18.10% | Upgrade
|
| EPS (Basic) | 0.01 | -0.03 | -0.11 | -0.20 | -0.24 | -0.91 | Upgrade
|
| EPS (Diluted) | 0.01 | -0.03 | -0.11 | -0.20 | -0.24 | -0.91 | Upgrade
|
| Free Cash Flow | 3.73 | -0.09 | -2.76 | -3.74 | -5.08 | 0.18 | Upgrade
|
| Free Cash Flow Per Share | 0.11 | -0.00 | -0.08 | -0.12 | -0.20 | 0.01 | Upgrade
|
| Gross Margin | 16.05% | 17.51% | 18.89% | 16.59% | 17.57% | 17.28% | Upgrade
|
| Operating Margin | 1.74% | -0.97% | -6.31% | -20.45% | -10.64% | -11.10% | Upgrade
|
| Profit Margin | 0.48% | -2.37% | -8.29% | -14.22% | -14.39% | -57.25% | Upgrade
|
| Free Cash Flow Margin | 8.15% | -0.20% | -6.09% | -8.41% | -12.04% | 0.47% | Upgrade
|
| EBITDA | 1.04 | -0.03 | -2.19 | -8.44 | -3.67 | -3.73 | Upgrade
|
| EBITDA Margin | 2.28% | -0.06% | -4.82% | -18.98% | -8.69% | -9.67% | Upgrade
|
| D&A For EBITDA | 0.25 | 0.4 | 0.67 | 0.65 | 0.82 | 0.55 | Upgrade
|
| EBIT | 0.8 | -0.43 | -2.86 | -9.09 | -4.49 | -4.27 | Upgrade
|
| EBIT Margin | 1.74% | -0.97% | -6.31% | -20.45% | -10.64% | -11.10% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.